CT45A6: A Potential Drug Target and Biomarker (G541465)

Target Name: CT45A6

NCBI ID: G541465

CT45A6

CT45A6: A Potential Drug Target and Biomarker

CT45A6 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. Its function is not well understood, but it is known to be involved in the regulation of cell survival and proliferation. As a potential drug target, CT45A6 has been identified as a promising target for small molecule inhibitors.

The protein encoded by the CT45A6 gene is 45 amino acids long and has a calculated molecular weight of 53.9 kDa. It is a single transmembrane protein that is expressed in a variety of tissues, including the brain, heart, and liver. It is highly conserved, with a conservation score of 0.76 in the database, and has been shown to be involved in the regulation of cell survival and proliferation.

One of the most promising aspects of CT45A6 is its potential as a drug target. The protein is known to be involved in the regulation of cell survival and proliferation, which makes it an attractive target for small molecule inhibitors. Small molecules have been shown to be effective in inhibiting the activity of CT45A6, and several compounds have been shown to be potent inhibitors.

In addition to its potential as a drug target, CT45A6 has also been identified as a potential biomarker. The protein is highly expressed in various tissues of the body, including the brain, heart, and liver, and has been shown to be involved in the regulation of cell survival and proliferation. This makes it an attractive target for diagnostic tests, as well as for the development of potential therapeutic approaches.

The discovery of CT45A6 as a potential drug target and biomarker has important implications for the development of new treatments for a variety of diseases. The protein is known to be involved in the regulation of cell survival and proliferation, which makes it an attractive target for small molecule inhibitors. Further research is needed to understand its full function and to develop effective inhibitors.

In conclusion, CT45A6 is a protein that has potential as a drug target and biomarker. Its function is not well understood, but it is known to be involved in the regulation of cell survival and proliferation. Further research is needed to understand its full function and to develop effective inhibitors.

Protein Name: Cancer/testis Antigen Family 45 Member A6

The "CT45A6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CT45A6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets